Department of Radiology, National Institute for Cancer Research (IST), University of Genova, Genova 16132, Italy.
Eur J Endocrinol. 2011 Mar;164(3):335-40. doi: 10.1530/EJE-10-0896. Epub 2010 Dec 13.
Mammographic density is a strong independent risk factor for breast cancer, whose prevalence in acromegaly is still controversial.
To compare breast density in premenopausal acromegalic patients and controls and to determine whether density correlated with disease duration, GH, and IGF1 levels.
DESIGN, SETTING AND PARTICIPANTS: A prospective study involving 30 patients and 60 controls matched for age and body mass index.
A quantitative computer-aided mammographic density estimation (MDEST) and a qualitative blind evaluation by two experienced radiologists using the breast imaging reporting and data system (BI-RADS) was performed. Totally, 60 (acromegaly) and 120 (controls) craniocaudal and mediolateral oblique mammograms were evaluated in both patients and controls.
Breast density.
Patients showed a significantly (P<0.01) increased mammographic breast density with both methods (MDEST: 0.33 ± 0.21% and BI-RADS category: 2.81 ± 0.78) in comparison with controls (MDEST: 0.26 ± 0.19% and BI-RADS category: 2.35 ± 0.61). The agreement between the two methods and inter-observer agreement between the two radiologists were excellent (k=0.63 and k=0.85). In patients grouped according to disease activity (17 controlled and 13 uncontrolled) and medical therapy (15 treated and 15 untreated), no differences were found. All these groups had significantly increased mammographic breast density compared with controls (P<0.01). A positive correlation was found between mammographic breast density, IGF1 values and disease duration (r=0.29 and r=0.39), whereas it was not found with GH (r=-0.02).
Mammographic breast density in premenopausal acromegalic patients is significantly higher than controls and positively correlated with IGF1 and disease duration.
乳腺密度是乳腺癌的一个独立强危险因素,肢端肥大症患者中乳腺密度的患病率仍存在争议。
比较绝经前肢端肥大症患者与对照组的乳腺密度,并确定乳腺密度是否与疾病持续时间、GH 和 IGF1 水平相关。
设计、地点和参与者:这是一项前瞻性研究,共纳入 30 例患者和 60 例年龄和体重指数匹配的对照组。
使用定量计算机辅助乳腺密度估计(MDEST)和两位经验丰富的放射科医生进行的盲法定性评估,使用乳腺影像报告和数据系统(BI-RADS)进行评估。共评估了患者和对照组的 60 例(肢端肥大症)和 120 例(对照组)头尾位和内外斜位乳腺 X 线片。
乳腺密度。
与对照组(MDEST:0.26±0.19%,BI-RADS 分级:2.35±0.61%)相比,患者的乳腺 X 线摄影密度显著增加(P<0.01),两种方法(MDEST:0.33±0.21%,BI-RADS 分级:2.81±0.78%)。两种方法之间以及两位放射科医生之间的观察者间一致性均极好(κ=0.63 和 κ=0.85)。根据疾病活动(17 例控制和 13 例未控制)和药物治疗(15 例治疗和 15 例未治疗)对患者进行分组后,未发现差异。与对照组相比,所有这些组的乳腺 X 线摄影密度均显著增加(P<0.01)。乳腺密度与 IGF1 值和疾病持续时间呈正相关(r=0.29 和 r=0.39),但与 GH 无相关性(r=-0.02)。
绝经前肢端肥大症患者的乳腺 X 线摄影密度明显高于对照组,且与 IGF1 和疾病持续时间呈正相关。